Abstract:Auxiliary KChIP4a shares high homology of conserved C-terminal core region with other members of Kv channel-interacting proteins (KChIPs), but exhibits a distinct modulation on Kv4 current expression and gating. It has been shown that the unique N-terminus of KChIP4a functions as K+ channel inactivation suppressor (KIS) that leads to slow inactivation and current inhibition. However, the mechanism by which the KIS domain causes current reduction remains unknown. In this study, we identified a hydrophobic ER-retention motif within the KIS domain of KChIP4a that suppresses Kv4.3 surface expression using confocal imaging and cell surface biotinylation assay. Further dissection of KIS domain revealed several key residues that cause reduction of Kv4.3 peak current, but do not affect surface expression. Examination of gating properties of Kv4.3 co-expressed with either KChIP4a or its core without the KIS (KChIP4aΔ2-34) demonstrated that KChIP4a with KIS domain had no significant effect on steady-state activation, but shifted the voltage dependence of steady-state inactivation of Kv4.3 to hyperpolarizing direction by enhancing closed-state inactivation. We have previously demonstrated that KChIP4a can rescue the function of a tetramerization-defect mutant Kv4.3 C110A. The rescued Kv4.3 C110A current is larger than that of WT Kv4.3/KChIP4a co-expression, although C110A surface expression was lower. Upon coexpression, the closed-state inactivation of Kv4.3 C110A mutant was less affected by the KIS domain, as compared with enhanced closed-state inactivation observed in wild-type channel, suggesting a role of T1 domain in mediation of Kv4 closed-state inactivation. Taken together, we propose that N-terminal KIS domain of KChIP4a inhibits Kv4.3 function through dual independent mechanisms by which auxiliary KChIP4a causes Kv4 ER retention and promotes channel closed-state inactivation.

Different Residues in Channel Turret Determining the Selectivity of ADWX-1 Inhibitor Peptide Between Kv1.1 and Kv1.3 Channels.

Structural Basis of a Potent Peptide Inhibitor Designed for Kv1.3 Channel, a Therapeutic Target of Autoimmune Disease

Design, Synthesis and Functional Validation of Peptide Inhibitors Based on TRPV1 Ion Channel Agonist RhTx.

Enhanced Trafficking of Tetrameric Kv4.3 Channels by KChIP1 Clamping

Enhancement of Closed-State Inactivation and ER Retention of Kv4.3 Mediated by N-Terminal KIS Domain of Auxiliary KChIP4A

The Tetramerization Domain Potentiates Kv4 Channel Function by Suppressing Closed-State Inactivation.

Selective Inhibition of TRPM2 Channel by Two Novel Synthesized ADPR Analogues

A-Type Kv4 Channel Closed-State Inactivation is Modulated by the Tetramerization Domain Interacting with Auxilary KChIP4a

Rational Design and Validation of a Vanilloid-Sensitive TRPV2 Ion Channel.

Structural Insights into KChIP4a Modulation of Kv4.3 Inactivation

Engineering a Peptide Inhibitor Towards the KCNQ1/KCNE1 Potassium Channel (Iks)

The antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blocker

An engineered scorpion toxin analogue with improved Kv1.3 selectivity displays reduced conformational flexibility

A Kv2 inhibitor combination reveals native neuronal conductances consistent with Kv2/KvS heteromers

Absolute Structure Determination and Kv1.5 Ion Channel Inhibition Activities of New Debromoaplysiatoxin Analogues

Single Amino Acid Substitution in α-Conotoxin TxID Reveals a Specific α3β4 Nicotinic Acetylcholine Receptor Antagonist.

Molecular Mechanism Underlying the Subtype-Selectivity of Competitive Inhibitor NF110 and Its Distinct Potencies in Human and Rat P2X3 Receptors

Rearrangement of a unique Kv1.3 selectivity filter conformation upon binding of a drug

Molecular Determinants of Species Specificity of α-Conotoxin TxIB towards Rat and Human α6/α3β4 Nicotinic Acetylcholine Receptors

Identification and Optimization of 2‐aminobenzimidazole Derivatives As Novel Inhibitors of TRPC4 and TRPC5 Channels

Open channel block of Kv1.5 channels by HMQ1611